Validation of the Proposed Definition for Complicated Coagulase-negative Staphylococcal Bacteremia
Clinical Infectious Diseases · 18.07.2025 · 80 (6) · 1208-1215
DOI: 10.1093/cid/ciaf119 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 13.03.2025. Verfasst von Matthaios Papadimitriou-Olivgeris und 2 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Bacteremia, Staphylococcal Infections, Staphylococcus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
A new definition for complicated coagulase-negative staphylococcal (CoNS) bacteremia was recently proposed. The aim of this study was to identify predictors of mortality in patients with CoNS bacteremia and evaluate the proposed definition of complicated bacteremia.
Methods
This retrospective study was conducted at the Lausanne University Hospital, Switzerland (2015–2023) and included adult patients with CoNS bacteremia.
Results
During the study period, 326 episodes of CoNS bacteremia were included, with 250 (77%) episodes involving Staphylococcus epidermidis. Most infections were catheter-related bacteremias (233 episodes; 68%). Based on the proposed definition, 195 (60%) episodes had complicated disease. The overall 30-day mortality was 9% (29 episodes). Infectious diseases (ID) consultation was provided within 48 hours from bacteremia onset in 285/326 (87%) episodes. Source control was deemed necessary in 275 (84%) episodes and was performed within 48 hours in 167/275 (61%) episodes. No difference on 30-day mortality was observed among complicated and uncomplicated disease (10% vs 7%; P = .327). The Cox multivariable regression model showed that a Charlson comorbidity index >4 (adjusted hazard ratio, 3.80; 95% confidence interval, 1.52–9.47) was associated with 30-day mortality, whereas ID consultation within 48 hours (0.22, 0.10–0.48) and performance of source control interventions within 48 hours (0.12, 0.03–0.50) were associated with improved outcome. Complicated disease was not associated with 30-day mortality (0.39, 0.10–1.46).
Conclusions
The proposed definition for complicated CoNS bacteremia failed to identify patients at higher risk for mortality in our cohort. Our findings highlight the importance of ID consultation in guiding antimicrobial treatment and recommending source control interventions for patients with CoNS bacteremia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Infectious Diseases Service, Institut Central des Hôpitaux and Hospital of Valais, Sion, Switzerland.
- Infection Prevention and Control Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
ORCID-Profile: Matthaios Papadimitriou-Olivgeris
Zitieren
APA
Papadimitriou-Olivgeris, M., Senn, L., & Guery, B. (2025). Validation of the Proposed Definition for Complicated Coagulase-negative Staphylococcal Bacteremia. Clinical Infectious Diseases, 80(6), 1208-1215. https://doi.org/10.1093/cid/ciaf119
Vancouver
Papadimitriou-Olivgeris M, Senn L, Guery B. Validation of the Proposed Definition for Complicated Coagulase-negative Staphylococcal Bacteremia. Clinical Infectious Diseases. 2025;80(6):1208-1215. doi:10.1093/cid/ciaf119
BibTeX
@article{PapadimitriouOlivgeris2025,
author = {Papadimitriou-Olivgeris, Matthaios and Senn, Laurence and Guery, Benoit},
title = {Validation of the Proposed Definition for Complicated Coagulase-negative Staphylococcal Bacteremia},
journal = {Clinical Infectious Diseases},
year = {2025},
volume = {80},
number = {6},
pages = {1208--1215},
doi = {10.1093/cid/ciaf119}
}
EUVIMED